Fundraising Fox
Capra Biosciences
Alexandria, US · Founded 2020 · Delaware corporation · 27 employees on LinkedIn · 8 known investors
Find your way into Capra Biosciences
Sign up to see every warm intro you have to Capra Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Capra Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Capra Biosciences was founded in 2020 by Andrew Magyar and Elizabeth Onderko.
Board
PW
DJ
DC
Investors · 8
Alumni Ventureslisted by Alumni VenturesManchester · $100K – $10M
How we know: av.vc · Not right? Tell us
Blue Ivy Ventureslisted by Blue Ivy VenturesBoston
How we know: Blue Ivy Ventures's portfolio page · Not right? Tell us
First Bight Ventureslisted by First Bight VenturesHouston · $1M – $2M
How we know: First Bight Ventures's portfolio page · press coverage · Not right? Tell us
GS Futureslisted by GS FuturesSeoul
How we know: press coverage · the VCSheet dataset · Not right? Tell us
SOSVlisted by SOSVNew York · $30K – $550Kvia Pae Wu · board
How we know: board seat on SEC Form D · press coverage · open dataset · 5k.vc investor directory · sosv.com · Not right? Tell us
The E14 Fundlisted by The E14 FundCambridge · $1M – $5M
How we know: the VCSheet dataset · e14.vc · Not right? Tell us
Closed Loop PartnersreportedNew York · $100K – $1M
How we know: funding news · press coverage · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$4M disclosed across 3 rounds · 2021–2024
▶$500KraisedOct 2024 · 1 investors · Other TechnologyRule 506(b)
▶$500KraisedOct 2024 · 1 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Andrew MagyarExecutive Officer, Director
- Elizabeth OnderkoExecutive Officer, Director, Promoter
- Pae WuDirector
- Douglas CameronDirector
- Danielle JosephDirector
- Offering amount
- $1.5M
- Amount sold
- $500K
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$3.4MraisedDec 2023 · 9 investors · Other TechnologyRule 506(b)
▶$3.4MraisedDec 2023 · 9 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Pae WuDirector
- Danielle JosephDirector
- Andrew MagyarExecutive Officer, Director, Promoter
- Douglas CameronDirector
- Elizabeth OnderkoExecutive Officer, Director, Promoter
- Offering amount
- $5M
- Amount sold
- $3.4M
- First sale
- Nov 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$50KraisedJan 2022 · 1 investors · Other TechnologyRule 506(b)
▶$50KraisedJan 2022 · 1 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Elizabeth OnderkoExecutive Officer, Director, Promoter
- Andrew MagyarExecutive Officer, Director, Promoter
- Offering amount
- $1.5M
- Amount sold
- $50K
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 8
Cambrian BioCambrian Bio is a clinical-stage drug development company creating precision therapeutics that target metabolic pathways which decline with age, such as AMPK and mTOR. Its lead asset, ATX-304, is an AMPK Network Activator being developed for obesity and prediabetes.
Capricor TherapeuticsCapricor Therapeutics is a biotechnology company developing allogeneic cardiosphere-derived cell (CDC) and exosome-based therapeutics to treat serious diseases including Duchenne muscular dystrophy. The company uses cell and exosome biology platforms to create novel therapeutic medicines for patient treatment.
Bicara TherapeuticsBicara Therapeutics is a clinical-stage biopharmaceutical company developing bifunctional antibody therapies that combine tumor-targeting with immune-modulating payloads to treat solid tumors. The company's lead program, ficerafusp alfa, fuses an EGFR-directed antibody with a TGF-β ligand trap to simultaneously inhibit tumor cell growth and suppress immunosuppressive signaling in the tumor microenvironment, with initial development focused on head and neck squamous cell carcinoma.
Pacira NASDAQ: PCRX www.pacira.comPacira develops and commercializes non-opioid therapies for postsurgical, chronic, and musculoskeletal pain, and is advancing a gene therapy pipeline candidate. It serves patients and healthcare providers seeking alternatives to opioid pain management.
BIOVECTRABIOVECTRA is a contract development and manufacturing organization (CDMO) with research and development capabilities in biologics process development, complex chemistry, and analytical development. Its work spans recombinant proteins, viral vectors, mRNA vaccines, and pharmaceutical process development for the biotech and pharmaceutical industries.
Fortis Life SciencesFortis Life Sciences develops and manufactures Bethyl-branded ELISA kits and related reagents, buffers, and antibodies for detecting target proteins in research and diagnostic applications. The kits cover human and veterinary targets and are made in the USA using the company's own antibodies.
BridgebioBridgeBio develops treatments for genetic conditions and cancers using a decentralized hub-and-spoke model, where autonomous teams focus on specific diseases or drug candidates while a central hub provides clinical, regulatory, and commercial support. The company partners with academic institutions to advance early-stage research toward late-stage clinical trials.
PrivcoPrivCo provides sales teams with company intelligence and prospect targeting tools, including verified contact data for decision makers, financial information, and competitive insights to support targeted outreach and qualification.
Companies working in the same space as Capra Biosciences.
Frequently asked questions
- Who founded Capra Biosciences?
- Capra Biosciences was founded by Andrew Magyar, Elizabeth Onderko in 2020.
- Who are Capra Biosciences's investors?
- Capra Biosciences's investors include Alumni Ventures, Blue Ivy Ventures, First Bight Ventures, GS Futures, SOSV, The E14 Fund, Closed Loop Partners, Groundswell Ventures.
- How much funding has Capra Biosciences raised?
- Capra Biosciences has disclosed $4M raised across 3 rounds.
- Where is Capra Biosciences headquartered?
- Capra Biosciences is headquartered in Alexandria, US.